Vivakor’s Chairman, Matt Nicosia stopped by to discuss Vivakor, a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds, that extend or improve life. Vivakor generates revenues through the licensing or sale of its technologies.